Our Alzheimer’s Story
Jennifer and I were married for 58 years. If couples can say “we are having a baby,” I can say that “we had Alzheimer’s disease.” When she became ill with Alzheimer’s, her story became our story. Jennifer and I [View More]
Andrea’s Alzheimers Story
My mom was such a lively and outgoing person, turning strangers into friends anywhere she went. She was like a superwoman; involved in everything her three daughters did like dance and art classes while she also worked part-time as [View More]
Activities for Persons with Alzheimer’s Disease
In his 1996 novel, The Notebook, author Nicholas Sparks describes a scene in which the main characters, Noah and Allie, learn that Allie has Alzheimer’s disease. “Alzheimer's... It is a barren disease, as empty and lifeless as a desert. It [View More]
Another Promising Treatment for Alzheimer’s disease
Last week, Eli Lilly and Company announced that it has applied for U.S Food and Drug Administration (FDA) approval for its Alzheimer’s treatment, donanemab, and expects an FDA decision by the end of 2023. The data, released by Lilly, [View More]
FDA Grants Full Approval to Leqembi® and Medicare Expands Coverage
On Thursday, July 6, Leqembi® (lecanemab – irmb), became the first beta-amyloid targeting medication for the treatment of Alzheimer’s disease to receive full approval from the U.S. Food and Drug Administration (FDA). The drug, from pharmaceutical companies Eisai and Biogen, received [View More]
Spring Gala Celebrating Connections
Spring Gala Celebrating Connections At the Gala on April 27, Alzheimer’s New Jersey was pleased to recognize two leaders in the New Jersey fight against Alzheimer’s disease. Russell Rothman and Heather Rae Stafford were each presented with the [View More]
FDA Approves Leqembi™
On Friday, January 6, the US Food and Drug Administration gave accelerated approval to Leqembi™ (lecanemab – irmb), a drug developed by Eisai in partnership with Biogen, for the treatment of Alzheimer’s disease. The drug is approved for use by [View More]
Embracing Your “Land of Hope and Dreams”
I’ve been a fan of Bruce Springsteen’s music for as long as I can remember. His “stories” have spoken to me in different ways during different periods of my life. Perhaps, that comes from living and growing up in [View More]
Lecanemab Clinical Trial Data
Recently released data from Eisai’s Phase 3 clinical trial of lecanemab shows that the drug slowed the rate of cognitive decline by 27% as compared to the placebo group in an 18-month study of participants experiencing the early stage of [View More]
Ken Zaentz Featured on NJ Morning Show
Watch Alzheimer's New Jersey CEO Ken Zaentz discuss the impact of Alzheimer's on the New Jersey Morning Show